A recent study demonstrated the critical roles of estrogen receptors and the efficacies of anti-estrogen therapy in both pancreatic cancer cell’s proliferation as well as cancer progression’s inhibition [41]. The gene discussed is ESR1; the disease is familial pancreatic carcinoma.